Table 1.
Percentage of involved ICC cases with CNV gain or loss
Chromosome arm | ICC | Studies (no) | Koo et al. [7] (Korea) | Wong et al. [10] (Hong Kong) | Lee et al. [8] (Korea) | Uhm et al. [9] (Korea) | Homayounfar et al. [6] (Germany) | Moinzadeh et al. [15] HCC (31 studies) |
---|---|---|---|---|---|---|---|---|
Cases (no.) | 98 | 5 | 11 | 13 | 33 | 19 | 22 | 785 |
1p- | 28 | 3 | 21 | 37 | 27 | |||
3p- | 53 | 2 | 38 | 68 | ||||
3q- | 23 | 1 | 23 | |||||
4p- | 36 | 1 | 36 | |||||
4q- | 35 | 4 | 46 | 21 | 32 | 41 | 34 | |
5q- | 26 | 1 | 26 | |||||
6q- | 69 | 2 | 46 | 91 | ||||
8p- | 33 | 3 | 31 | 26 | 41 | 38 | ||
9p- | 40 | 3 | 38 | 26 | 55 | |||
9q- | 36 | 1 | 36 | |||||
11p- | 23 | 1 | 23 | |||||
11q- | 23 | 1 | 23 | |||||
12q- | 23 | 1 | 23 | |||||
13q- | 45 | 1 | 45 | 26 | ||||
14q- | 43 | 2 | 31 | 55 | ||||
16q- | 0 | 0 | 36 | |||||
17p- | 40 | 3 | 55 | 38 | 26 | 32 | ||
18q- | 31 | 3 | 38 | 32 | 23 | |||
19p- | 32 | 1 | 32 | |||||
21q- | 23 | 1 | 23 | |||||
1p+ | 23 | 1 | 23 | |||||
1q+ | 40 | 3 | 54 | 24 | 41 | 57 | ||
2q+ | 26 | 1 | 26 | |||||
3q+ | 37 | 2 | 46 | 27 | ||||
5p+ | 28 | 3 | 27 | 24 | 32 | |||
5q+ | 27 | 2 | 31 | 23 | ||||
6p+ | 0 | 0 | 22 | |||||
7p+ | 28 | 3 | 27 | 26 | 32 | |||
7q+ | 36 | 1 | 36 | |||||
8p+ | 39 | 1 | 39 | |||||
8q+ | 45 | 4 | 36 | 54 | 58 | 32 | 47 | |
11q+ | 37 | 2 | 31 | 42 | ||||
12p+ | 27 | 1 | 27 | |||||
12q+ | 23 | 1 | 23 | |||||
13q+ | 45 | 1 | 45 | |||||
15q+ | 37 | 2 | 38 | 36 | ||||
16p+ | 36 | 1 | 36 | |||||
17q+ | 42 | 3 | 38 | 61 | 26 | 22 | ||
18p+ | 39 | 1 | 39 | |||||
18q+ | 27 | 2 | 27 | 26 | ||||
19q+ | 26 | 1 | 26 | |||||
20q+ | 45 | 3 | 36 | 31 | 67 |